| Company Name | Amount Raised | Type of Fundraise | Country | Date |
| Private company financings | ||||
| Nuevocor | $45 million | Series B | Singapore | 6 May |
| PAQ Therapeutics | $30 million | Series B | US | 6 May |
| NewLimit | $130 million | Series B | US | 6 May |
| HAYA Therapeutics | $65 million | Series A | Switzerland | 8 May |
| Stylus Medicine | $85 million | Series A | US | 13 May |
| Azafaros | $146 million | Series B | Netherlands | 13 May |
| Pathos AI | $365 million | Series D | US | 15 May |
| CellCentric | $120 million | Series C | UK | 19 May |
| ReproNovo | $65 million | Series A | Switzerland | 21 May |
| Juvenescence | $76 million | Series B-1 | UK | 21 May |
| ProteinQure | $11 million | Series A | Canada | 27 May |
| Syndeio | $90 million | Seed | US | 27 May |
| GlycoEra | $130 million | Series B | Switzerland | 27 May |
| Brooklyn Health | $6.5 million | Seed | US | 27 May |
| Public company financings | ||||
| Aura Biosciences | $75 million | CMPO | US | 12 May |
| Sangamo Therapeutics | $23 million | RD | US | 12 May |
| CytomX Therapeutics | $100 million | RD | US | 12 May |
| Hinge Health | $437 million | IPO | US | 22 May |